Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to investigate the efficacy of levalbuterol 90 ug (2
actuations, 45 ug each) versus placebo (2 actuations) in the treatment and prevention of
bronchoconstriction in adolescent and adult subjects with asthma, with all treatments
administered 4 times a day (QID).